Axtria
PrivateLast Round
Private Equity
9/23/2025
Total Funding Raised
$443.9M
Company Overview
Axtria is a global provider of cloud software and data analytics solutions specifically for the life sciences industry. The company develops platforms that utilize artificial intelligence and machine learning to help pharmaceutical, biotechnology, and medical device companies manage data and optimize commercial operations. Its key product suites—including Axtria DataMAx™, Axtria SalesIQ™, Axtria InsightsMAx™, Axtria MarketingIQ™, and Axtria CustomerIQ™—enable clients to transform their data into actionable insights for sales, marketing, and overall business strategy. Founded in 2010, Axtria aims to improve healthcare outcomes by helping connect the right therapies to the right patients.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Sales Enablement, Data Integration, Clinical Trials, CRM
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axtria Comps
Public and private peers based on sector, stage, and business model.
Axtria Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | 9/23/2025 | ||||
| Growth Equity | 5/13/2021 | ||||
| Series C | 12/21/2018 | ||||
| Series C | 7/8/2015 | ||||
| Series B | 1/6/2015 | ||||
VC Round | 1/9/2014 |
Axtria Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helion Venture Partners | Series C |
| Sequoia Capital | Series A |
| Bain Capital Tech Opportunities | Growth Equity |
| Bain Capital, LP | Growth Equity |
| Kedaara | Private Equity |
| Sequoia Capital India | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Partnered with LangChain, creators of the LangSmith platform.
- Apr 15, 2026
Acquired Conexus Solutions, a CRM transformation specialist for life sciences.
Axtria Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axtria's valuation, stock price, and market status.
